ProShares Ultra NASDAQ Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIB and other ETFs, options, and stocks.

About BIB

BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. The listed name for BIB is ProShares Trust ProShares Ultra Nasdaq Biotechnology. 

Index-Tracked
NASDAQ Composite TR USD
Index-TrackedNASDAQ Composite TR USD
Category
Trading--Leveraged Equity
CategoryTrading--Leveraged Equity
Number of holdings
268
Number of holdings268
Inception Date
Apr 6, 2010
Inception DateApr 6, 2010

BIB Key Statistics

AUM
80.21M
AUM80.21M
Price-Earnings ratio
Price-Earnings ratio
30-Day yield
30-Day yield
Average volume
13.75K
Average volume13.75K
High today
$80.32
High today$80.32
Low today
$78.53
Low today$78.53
Open price
$78.53
Open price$78.53
Volume
5.77K
Volume5.77K
52 Week high
$90.91
52 Week high$90.91
52 Week low
$33.78
52 Week low$33.78
Expense ratio
1.19
Expense ratio1.19

Stock Snapshot

With a market cap of 80.99M, ProShares Ultra NASDAQ Biotech(BIB) trades at $80.20.

On 2026-03-16, ProShares Ultra NASDAQ Biotech(BIB) stock moved within a range of $78.53 to $80.32. With shares now at $80.20, the stock is trading +2.1% above its intraday low and -0.1% below the session's peak.

Trading volume for ProShares Ultra NASDAQ Biotech(BIB) stock has reached 5.77K, versus its average volume of 13.75K.

Over the past 52 weeks, ProShares Ultra NASDAQ Biotech(BIB) stock has traded between a high of $90.91 and a low of $33.78.

Over the past 52 weeks, ProShares Ultra NASDAQ Biotech(BIB) stock has traded between a high of $90.91 and a low of $33.78.

Average Annual Return

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.